Pfizer’s $70 billion deal with the U.S. government is essentially a Pay-Off

Pfizer’s $70 billion deal with the U.S. government is essentially a Pay-Off

By Lance D Johnson

Post on October 3, 2025

As Pfizer basks in record-breaking profits from its COVID-19 vaccine—now the most lucrative pharmaceutical product in history—the company has quietly secured a golden shield against accountability for the problems that vaccine caused. In a stunning move, Pfizer has pledged $70 billion in U.S. investments and steep Medicaid price cuts in exchange for preferential treatment under Trump’s “most favored nation” (MFN) drug pricing scheme. This deal effectively immunizes Pfizer from tariffs and scrutiny while locking the U.S. government into a long-term dependency on its products. Meanwhile, thousands of vaccine-injured Americans are left without justice as Pfizer executives, like CEO Albert Bourla, evade indictment for ignoring and downplaying early warnings of serious harm with their experimental vaccine.

This isn’t just corporate maneuvering—it’s a calculated escape from liability. By embedding itself into government healthcare programs, Pfizer ensures its dominance over the medical industry while sidestepping responsibility for the injuries and deaths linked to its mRNA shots. With full FDA approval and aggressive marketing campaigns, Pfizer now pushes its vaccines on children as young as five, despite unresolved safety concerns. The company’s $2.8 billion advertising budget floods news networks like CNN and ABC, shaping public perception while suppressing unfavorable side effect disclosures.

The truth is clear: Pfizer isn’t just profiting from a scam of epic, coercive proportions—it’s profiting from the suffering it helped create. And with the U.S. government now financially tethered to Pfizer’s discounted drugs, the pharmaceutical giant has rendered itself untouchable.

Key points:

• • Pfizer’s COVID vaccine generated $37.8 billion in 2022, with profits soaring into the “high 20s” margin.

• • The company secured a three-year tariff exemption and government favoritism in exchange for $70 billion in U.S. investments and Medicaid price cuts.

• • Pfizer dominates 74% of the U.S. vaccine market, pushing its shots on children despite concerns over natural immunity and adverse events.

• • Aggressive marketing partnerships with major news networks suppress negative coverage of vaccine injuries.

• • The Trump administration’s MFN deal locks Pfizer into government healthcare programs, ensuring long-term profits while shielding the company from liability.

Pfizer’s vaccine windfall and the cost of silence

Pfizer’s financial success is staggering—but it comes at a devastating human cost. The company’s mRNA vaccine, developed with BioNTech, has become a cash cow, raking in $13 billion in just one quarter. Yet, buried beneath the earnings reports are thousands of reports of severe adverse reactions, including myocarditis, blood clots, and autoimmune disorders. Despite this, Pfizer enjoys near-total legal immunity under the Public Readiness and Emergency Preparedness (PREP) Act, which shields vaccine manufacturers from lawsuits during declared health emergencies.

Now, with the MFN deal, Pfizer has further insulated itself from accountability. By offering steep discounts on Medicaid drugs and funneling billions into U.S. production, the company has bought political goodwill—ensuring that regulators turn a blind eye to mounting evidence of vaccine harm. This isn’t philanthropy; it’s a calculated business move. As Pfizer’s stock surges, injured patients struggle to find doctors willing to acknowledge their suffering, let alone hold the company responsible.

Marketing the narrative: How Pfizer controls the media

Pfizer’s influence extends far beyond government deals. The company sponsors major news programs like Good Morning America, Anderson Cooper 360°, and CNN Tonight, ensuring favorable coverage while sidelining critical voices through shadow banning and demonetization strategies coordinated through social media platforms. By avoiding direct vaccine advertisements, Pfizer bypasses FDA-mandated side effect disclosures—keeping the public in the dark about risks.

This media manipulation mirrors Big Pharma’s past tactics, such as Purdue Pharma’s covert funding of opioid advocacy groups. The result? A carefully crafted narrative that portrays Pfizer as a savior while dismissing vaccine injuries as “rare” or “coincidental.” Meanwhile, independent researchers and whistleblowers face censorship, their findings buried under a flood of pharmaceutical-funded propaganda. In this deception, Pfizer remains unscathed and even praised, while bringing previous critics like Secretary Kennedy to heel, as Kennedy helped secure the $70 billion deal that made Pfizer look compassionate, innocent.

The MFN trap: How Pfizer bought its innocence

The Trump administration’s MFN policy was marketed as a win for consumers—but in reality, it’s a lifeline for Pfizer. By agreeing to price cuts on older drugs, the company secures guaranteed sales through Medicaid and TrumpRx.gov, a new federal direct-to-consumer platform. This ensures a steady revenue stream while Pfizer pushes its newer, pricier treatments—including COVID boosters and gene therapies—onto an unsuspecting public. Albert Bourla was giddy at the press conference in front of President Trump, Dr. Oz, and Secretary Kennedy. He mentioned that Pfizer will now be freed up to work on new mRNA jabs for cancer (completely disregarding the failures of the COVID mRNA jabs). Now, Bourla will have direct access to consumers through Trump’s new direct-to-consumer platform.

This deal also grants Pfizer a three-year reprieve from tariffs, effectively rewarding the company for past misconduct. While injured families fight for recognition for their vaccine injury and the death of their loved ones, Pfizer executives laugh all the way to the bank and look like the saviors once again. The message is clear: In America’s broken healthcare system, profits trump justice—and Pfizer has mastered the game.

Lance D Johnson

• https://newstarget.com/2025-10-01-pfizers-70-billion-deal-with-the-government-is-pay-off.html

Disposable vapes hooked a generation and the damage may be irreversible

Disposable vapes hooked a generation and the damage may be irreversible

By Lance D Johnson

Post on September 4, 2025

The high school hallway is thick with the saccharine scent of mango and cotton candy—a smell that doesn’t come from lunchboxes, but from the clouds of vapor exhaled by students between classes. Touted for years by health authorities as a “safer” alternative, vaping has instead blossomed into a full-blown public health crisis, one that has slipped through the fingers of regulators like smoke itself.

The numbers trace an alarming trajectory: between 2021 and 2024, vaping among young adults didn’t just rise—it exploded, overwhelmingly fueled by the cheap, sweet-flavored disposables that fit as easily into a backpack as a pack of gum. But behind the fruity aromas and sleek designs lies a grim reality that new research is forcing us to confront. Recent studies presented to both the European Respiratory Society and the American Heart Association reveal a devastating double blow: these devices can cause lung damage comparable to traditional cigarettes, while the volatile organic compounds they produce inflict significant cardiovascular harm.

This mounting evidence suggests vaping is rewiring developing brains and setting up a generation for a lifetime of health risks, directly challenging the long-standing safety claims now deemed dangerously premature. With cardiologists and pulmonologists sounding the alarm, the call for robust intervention and stricter regulations is growing louder, as the world races to curb a crisis it once mistakenly endorsed.

Key points:

• • Vaping among young adults surged from 17% to 26.5% between 2022 and 2024, driven by disposable e-cigarettes marketed with candy-like flavors and vibrant packaging.

• • New research reveals vaping may damage young lungs as severely as smoking, contradicting years of public health messaging that positioned e-cigarettes as a “less harmful” alternative.

• • Experts warn of irreversible harm to brains and hearts, with nicotine and toxic chemicals disrupting development in adolescents and young adults—some of whom have never touched a cigarette.

• • A University of California study linked vaping to a 32% higher stroke risk and a 24% increase in cardiovascular disease, while another review identified 133 harmful chemicals in e-cigarettes, 107 of which are carcinogenic.

• • Despite the risks, the NHS still promotes vaping as a smoking cessation tool, while critics argue the industry’s social media marketing and lack of age controls have turned a generation into lab rats for an unregulated experiment.

• • The UK has banned disposable vapes, but global calls for stricter action grow louder as long-term data remains scarce—and the potential fallout looms larger.

The bait and switch: How vaping went from “quit tool” to youth epidemic

When e-cigarettes first hit the market in the mid-2000s, they arrived with a promise: a way for smokers to kick the habit without the tar and toxins of traditional cigarettes. Public health agencies, including the UK’s NHS, cautiously endorsed them as a harm reduction tool, a lesser evil in the fight against lung cancer and emphysema. But somewhere along the way, the script flipped. The target audience wasn’t middle-aged smokers trying to quit—it was teenagers who had never lit up in their lives.

Professor Maja-Lisa Løchen, a senior cardiologist at the University Hospital of North Norway, didn’t mince words at this year’s European Society of Cardiology congress in Madrid. “We have the data,” she told a room full of fellow experts. “We know they are not harmless.” Her concern isn’t just about the immediate effects—it’s about the long-term rewiring of young brains and bodies. Nicotine, the addictive core of both cigarettes and vapes, is particularly dangerous for adolescents. Studies show it can alter brain development, impairing memory, attention, and impulse control well into adulthood. But vapes deliver more than just nicotine. Løchen’s presentation highlighted 133 potentially harmful chemicals lurking in e-cigarette aerosol, 107 of which are known carcinogens.

So how did we get here? The answer lies in a perfect storm of regulatory gaps, corporate marketing, and cultural shifts. Disposable vapes—cheap, colorful, and sold in flavors like “blue raspberry slushie”—flooded the market with little oversight. Social media platforms became the wild west of vape promotion, with industry-paid influencers pushing products to millions of young viewers. “This is a largely unregulated global market,” Løchen warned. “Vaping appeals to adolescents because it is very cheap, it tastes and smells like candy, it’s sold without age control, and perceived as harmless and fun.”

The result is a 26.5% vaping rate among young adults in 2024, up from 17% just two years prior. And unlike previous generations who picked up smoking as a rebellious rite of passage, many of these kids weren’t smokers first. “The most common reason for vaping in the young is not smoking cessation,” Løchen noted. “It’s curiosity.”

The body as a battleground: What vaping does to young lungs and hearts

If curiosity is the hook, the body pays the price. The European Respiratory Society’s recent findings dropped a bombshell: vaping may cause as much lung damage as smoking. This flies in the face of years of public health messaging that positioned e-cigarettes as the “healthier” choice. But the data doesn’t lie. A 2023 University of California study published in the New England Journal of Medicine found that vaping increases the risk of:

• • Stroke by 32%

• • Cardiovascular disease by 24%

• • Asthma by 24%

• • Chronic obstructive pulmonary disease (COPD) by 46%

• • Mouth diseases by 47%

For comparison, smoking’s risks were far higher—but the gap isn’t as wide as once believed. “It increases your blood pressure, your heart rate, and we know that the arteries become more stiff,” Løchen explained. “It could be even more harmful in children.”

Why? Because young bodies are still developing. The cardiovascular system, the lungs, the brain—all are in a delicate phase of growth that nicotine and toxic chemicals can disrupt permanently. “I worry that vaping may be causing irreversible harm to children’s brains and hearts,” Løchen said. “Of course, we have to wait for long-term data, but I am absolutely concerned.”

Professor Susanna Price, a consultant cardiologist at London’s Royal Brompton and Harefield hospitals, echoed those fears. “We are seeing an increase in children vaping, but what we don’t yet know is what that translates to in long-term cardiovascular risk because they haven’t been around long enough,” she said. “I think there is a push to suggest that vaping is safe, but we don’t know that.”

Fast forward to 2024, and vape companies are taking advantage of the situation:

• • Flavors that appeal to kids: Bubblegum, cotton candy, sour apple—these aren’t flavors designed for adults trying to quit smoking.

• • Social media saturation: TikTok, Instagram, and YouTube are flooded with vape influencers, often paid by brands to glamorize the habit.

• • Disposable, affordable, and easy to hide: Unlike cigarettes, which require a lighter and leave a smell, vapes slip into pockets and dissipate quickly.

• • Lack of age verification: Online and in-store sales often bypass ID checks, making it easy for minors to buy.

“This is not about harm reduction anymore,” Løchen said. “This is about creating a new generation of addicts.”

Experts suggest a multi-pronged approach to combat the issues:

• • Stricter marketing bans: No more cartoon packaging, no more social media ads targeting teens.

• • Flavor restrictions: Limit sales to tobacco and menthol only, eliminating the candy-like appeal.

• • Age verification crackdowns: Fines for retailers who sell to minors, both online and in stores.

• • Public health campaigns: Honest messaging about the risks, not just “vaping is better than smoking.”

• • Long-term studies: Fund independent research on vaping’s effects over decades, not just years.

But perhaps the most critical shift needs to happen in how we talk about addiction. For decades, the narrative around smoking was “just say no.” With vaping, the message got muddled: “It’s safer, so why not try it?” Now, we’re seeing the consequences.

Lance D Johnson

• https://newstarget.com/2025-09-02-disposable-vapes-hooked-a-generation-inflicting-irreversible-damage.html

10 lifestyle hacks to fortify your cardiovascular system

10 lifestyle hacks to fortify your cardiovascular system

By Lance D Johnson

Post on August 3, 2025

In a world where processed foods dominate grocery shelves and pharmaceutical companies push quick-fix solutions, the truth about heart health remains buried beneath layers of corporate greed and government-approved misinformation. While doctors and media pundits preach the same tired advice—exercise more, eat less fat—few dare to expose the real nutrients that fortify the heart against disease.

Key points:

• • Omega-3 fatty acids, critically under consumed in the U.S., support vascular function, healthy blood pressure, and balanced triglycerides—yet mainstream medicine still pushes statins instead.

• • Folate (B9) regulates homocysteine levels, a key factor in heart health, but synthetic folic acid in fortified foods is a poor substitute for bioactive 5-MTHF.

• • Vitamin C’s antioxidant power combats oxidative stress and supports endothelial function, yet its heart benefits are downplayed in favor of expensive drugs.

• • Resveratrol, the secret behind the “French Paradox,” protects blood vessels and fights inflammation—but its bioavailability is sabotaged unless paired with absorption boosters like piperine.

• • Lycopene, abundant in tomatoes, defends against LDL cholesterol and supports blood flow, yet processed food giants strip it from their products.

• • Nitric oxide boosters like beetroot relax blood vessels and reduce blood pressure.

• • Polyphenol-rich blueberries contain anthocyanins that improve arterial health.

1. Nitric oxide boosters (beetroot, leafy greens, spinach)

Nitrates in beets, spinach, and arugula convert into nitric oxide (NO)—a molecule so vital that its discovery earned the 1998 Nobel Prize in Medicine. NO relaxes blood vessels, reduces blood pressure, and enhances endurance. A landmark study published in Hypertension found that consuming one cup of beetroot juice daily for four weeks significantly lowered blood pressure. Athletes also benefit—research shows nitrate-rich diets improve oxygen efficiency, making beets a natural performance enhancer. This is nature’s pharmacy at work: simple, potent, and backed by science.

2. Omega-3 fatty acids (wild salmon, chia seeds, walnuts)

Omega-3s (EPA and DHA) are heart-protective superstars, reducing arterial plaque, lowering triglycerides, and stabilizing heart rhythms. The Journal of the American College of Cardiology confirms that just two servings of fatty fish per week slashes heart disease risk by 30%. For plant-based options, chia seeds and walnuts offer ALA—a precursor to EPA/DHA. Omega-3s also fight systemic inflammation, a silent contributor to atherosclerosis. Supplements can help, but wild-caught salmon and sardines deliver the full spectrum of benefits without processed fillers.

3. Fiber-rich foods (oats, lentils, apples)

Soluble fiber (pectin, beta-glucan) acts like a magnetic sweeper, binding to LDL cholesterol and shuttling it out of the body. Harvard research shows that 5-10g of daily fiber reduces heart attack risk by 14%. Steel-cut oats, lentils, and apples are ideal sources—their slow-digesting nature stabilizes blood sugar, preventing insulin spikes that stress the heart. Bonus? Fiber feeds gut microbiota, which produce anti-inflammatory compounds linked to vascular health.

4. Dark chocolate (70%+ cocoa)

Cocoa’s flavonoids (epicatechin, quercetin) enhance endothelial function, boosting blood flow. A 2017 meta-analysis found that 20g of dark chocolate daily lowered hypertension risk by 20%. Key? Minimal processing—raw cacao retains the highest polyphenol content. Avoid milk chocolate’s sugar overload, which negates benefits. Instead, savor a square post-meal—your arteries will thank you.

5. Regular aerobic exercise (brisk Walking, cycling, swimming)

150 minutes of moderate exercise weekly (Mayo Clinic guidelines) cuts heart disease mortality by 50%. Movement stimulates nitric oxide production, optimizing circulation. Cycling and swimming also strengthen cardiac output, while walking post-meal aids glucose metabolism. For those with sedentary jobs, mini-breaks (e.g., 2-minute stretches hourly) counteract stiffness. Consistency beats intensity—a 30-minute daily walk outperforms weekend warrior extremes.

6. Magnesium-rich foods (pumpkin seeds, almonds, dark leafy greens)

Magnesium moderates blood pressure, prevents arrhythmias, and relaxes vascular smooth muscle. A Nutrients journal meta-analysis revealed that low magnesium intake hikes CVD risk by 54%. Yet 50% of adults are deficient. Pumpkin seeds (156mg per ounce) and spinach (157mg per cup) are quick fixes. Pair with vitamin D (enhances absorption) and limit caffeine/alcohol, which deplete reserves.

7. Stress reduction (meditation, yoga, forest bathing)

Chronic stress inflames arteries and spikes cortisol, accelerating plaque formation. Studies show meditators have 48% lower stroke risk (Stroke Journal). Yoga’s deep breathing stimulates the vagus nerve, slowing heart rate. Shinrin-yoku (forest bathing)—10 minutes among trees—cuts stress hormones by 15%. Even 5-minute desk meditations reset your fight-or-flight response, shielding your heart.

8. Garlic (allicin)

Garlic’s allicin breaks down into sulfur compounds that reduce arterial stiffness. Trials show 600–1,200mg aged garlic extract daily lowers BP as effectively as drugs. For fresh cloves, crush and wait 10 minutes (activates enzymes). Roasted garlic loses potency—raw is superior. Pair with ginger for synergistic circulation benefits.

9. Sleep (7-9 hours nightly)

Poor sleep increases CRP (inflammation marker) and disrupts autonomic balance, straining the heart. Deep sleep triggers growth hormone release, repairing vascular tissue. For restless minds, magnesium glycinate or tart cherry juice (natural melatonin) can help. Blue light blockers post-8pm also preserve circadian rhythm.

10. Polyphenol-rich berries (blueberries, strawberries)

Blueberries, whether fresh or frozen, are nutritional powerhouses with multiple mechanisms that support heart health. Here’s a detailed breakdown of their benefits:

• • Oxidative stress, driven by free radicals, contributes to atherosclerosis (hardening/narrowing of arteries) by damaging the endothelium (inner artery lining).

• • Blueberries contain anthocyanins, potent antioxidants that scavenge free radicals, preventing oxidative damage to LDL cholesterol and arterial walls.

• • Studies show that regular berry consumption reduces markers of oxidative stress, lowering risks of plaque rupture and clot formation.

• • Anthocyanins in blueberries enhance nitric oxide (NO) production, promoting vasodilation (relaxation of blood vessels). This leads to improved arterial elasticity, reducing resistance in blood flow and lowering blood pressure—a key factor in preventing hypertension-related heart strain.

• • Frozen blueberries retain maximum anthocyanins due to flash-freezing immediately after harvest, often surpassing nutrient levels in out-of-season fresh berries.

• • Pterostilbene (a compound related to resveratrol in blueberries) helps lower oxidized LDL cholesterol, a major driver of atherosclerosis.

• Blueberries also inhibit foam cell formation (fat-laden immune cells that contribute to arterial plaque). Blueberries provide ~3.6g of fiber per cup, aiding bile acid excretion in the gut—forcing the liver to use cholesterol reserves, thereby reducing circulating LDL.

Lance D Johnson

• Source